Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration
about
APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT studyApolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activatorsThe human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response elementApolipoprotein A-V dependent modulation of plasma triacylglycerol: a puzzlementThe paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic researchInfluence of apolipoprotein A-V on the metabolic fate of triacylglycerolIs apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?Genetic polymorphism of apolipoprotein A5 gene and susceptibility to type 2 diabetes mellitus: a meta-analysis of 15,137 subjectsThyroid hormone regulates the hypotriglyceridemic gene APOA5Atorvastatin and fenofibrate increase apolipoprotein AV and decrease triglycerides by up-regulating peroxisome proliferator-activated receptor-alphaThe C terminus of apolipoprotein A-V modulates lipid-binding activity.Insulin-mediated down-regulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: role of upstream stimulatory factor.Interactions of the apolipoprotein A5 gene polymorphisms and alcohol consumption on serum lipid levels.Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment.Gene-gene interaction between APOA5 and USF1: two candidate genes for the metabolic syndromeInteractions between the APOA5 -1131T>C and the FEN1 10154G>T polymorphisms on ω6 polyunsaturated fatty acids in serum phospholipids and coronary artery disease.Intravenous injection of apolipoprotein A-V reconstituted high-density lipoprotein decreases hypertriglyceridemia in apoav-/- mice and requires glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1.APOA5 Q97X mutation identified through homozygosity mapping causes severe hypertriglyceridemia in a Chilean consanguineous family.Genetic determinants of plasma triglyceridesBiogenesis of apolipoprotein A-V and its impact on VLDL triglyceride secretion.Studies of gene variants related to inflammation, oxidative stress, dyslipidemia, and obesity: implications for a nutrigenetic approachApolipoprotein A-V deficiency enhances chylomicron production in lymph fistula miceAssociation of apolipoprotein A5 concentration with serum insulin and triglyceride levels and coronary artery disease in Korean men.Increased apolipoprotein A5 expression in human and rat non-alcoholic fatty livers.The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery diseaseInteractions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome.Give me A5 for lipoprotein hydrolysis!Apolipoprotein A-V is present in bile and its secretion increases with lipid absorption in Sprague-Dawley ratsInfluence of apolipoprotein A-V on hepatocyte lipid droplet formationDeterminants of plasma apolipoprotein A-V and APOA5 gene transcripts in humans.Structural and functional analysis of APOA5 mutations identified in patients with severe hypertriglyceridemia.An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients.Intracellular lipid droplet targeting by apolipoprotein A-V requires the carboxyl-terminal segmentGene transfer of apolipoprotein A-V improves the hypertriglyceridemic phenotype of apoa5 (-/-) mice.Apolipoprotein polymorphisms and familial hypercholesterolemia.Identification and characterization of cyclic AMP response element-binding protein H response element in the human apolipoprotein A5 gene promoter.Overexpression of apolipoprotein A5 in mice is not protective against body weight gain and aberrant glucose homeostasis.Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.The influence of statin-fibrate combination therapy on lipids profile and apolipoprotein A5 in patients with acute coronary syndromeApolipoprotein A-V N-terminal domain lipid interaction properties in vitro explain the hypertriglyceridemic phenotype associated with natural truncation mutants.
P2860
Q24305221-6F93D2A0-BAB9-47F0-AE79-AD68528A868AQ28183207-49E6166A-1305-413E-AA89-6033C6E1DDBCQ28199120-DFD6E5F3-B83C-41AA-ABF5-CD8DB224BA96Q28256394-102963F2-D3FF-4C1A-A4AC-16E5AA36ED37Q28275573-E462F815-7D85-4C3D-8F08-0753EB4CBB5FQ28281468-97FA5DCB-4AD8-4487-BE9C-B10FCE5C8310Q28294769-2907A466-3EBC-47CF-8104-C6634A6A619FQ28308177-2428C534-0C8A-4164-B2AD-2E219C10A0DCQ28569807-A2A0B9E1-CC35-4016-B511-18A0EFC3DB10Q28584176-B7C0FE66-C85E-42F5-972C-638C18761796Q30360807-8426CF75-C3F3-4875-B3EA-332FE101C952Q33823946-F12752DE-530C-4B4D-A022-664C09D29CBBQ33851689-9305CCDE-E97B-44CD-8380-4B911F59686EQ34048473-64655AD0-F14C-40D6-8DBB-3B893E70052BQ34057144-7EBC611C-BAFC-4515-97A5-4D0962DCADEDQ34188057-4F9E8CC1-4859-4183-9EAE-B3E4A92374F8Q34332478-252BCED9-6411-4068-B9AF-40CBC633A928Q34476810-B94280FE-1E6F-41BC-883F-DFCD82B349ADQ34503333-5E87034B-59BC-402D-B80C-85136155DBF1Q34503351-D4AFF298-90A6-4E2C-B873-4A0D06B1BA69Q35104849-46A9457B-C0C7-468E-A167-8EC446516256Q35274124-2D6713AB-7550-4310-A57A-93D2E6FE33F6Q35591965-79910AC9-BD7B-4CE7-BD2C-6598EFEEFC02Q35592272-CEE9F452-24B0-4C87-BB35-31871CB6DD81Q35596411-EB4D2D14-0815-4D6C-8479-40EE0399BD5FQ35908368-B0489DBE-0C2E-40AD-ACE2-05C31ED4B126Q36274976-C459EF76-25CC-4515-B99B-F4CD4C2AF8DCQ36345922-B1AAD85C-D5BA-407E-919F-92CE3F59ABC6Q36382853-17A856AF-7F75-4A7F-ABD1-1551AE506E98Q36496770-FFDB6A81-63AC-40FE-ACED-2CCAB2636726Q36744086-5DDBDC68-A5FE-4B87-B00F-2692FD8A9AE4Q36745050-3A9120E7-93FB-43A8-80EF-CD34C8A738CAQ36745069-786A7B02-2356-4C07-97BD-F8FEDDD2F82FQ36856055-6538BF1E-5ED6-439F-A8AB-FB104342DEACQ36966031-21599F95-834C-48AA-99AE-BEF159811C89Q37061267-4B4439CA-95BB-4FB7-BD67-137ECD5840EFQ37209161-B4A14401-A03C-4FD1-AAF0-1F174E957290Q37314809-E6225948-2688-41F7-B0E6-946824078340Q37363449-EB56CC52-41C4-4707-AF9A-CCC277BCD929Q37446164-EA915F76-7D28-4614-9D41-30DD1032668A
P2860
Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Apolipoprotein A-V: a novel ap ...... ly phase of liver regeneration
@ast
Apolipoprotein A-V: a novel ap ...... ly phase of liver regeneration
@en
Apolipoprotein A-V: a novel ap ...... ly phase of liver regeneration
@en-gb
Apolipoprotein A-V: a novel ap ...... ly phase of liver regeneration
@nl
type
label
Apolipoprotein A-V: a novel ap ...... ly phase of liver regeneration
@ast
Apolipoprotein A-V: a novel ap ...... ly phase of liver regeneration
@en
Apolipoprotein A-V: a novel ap ...... ly phase of liver regeneration
@en-gb
Apolipoprotein A-V: a novel ap ...... ly phase of liver regeneration
@nl
prefLabel
Apolipoprotein A-V: a novel ap ...... ly phase of liver regeneration
@ast
Apolipoprotein A-V: a novel ap ...... ly phase of liver regeneration
@en
Apolipoprotein A-V: a novel ap ...... ly phase of liver regeneration
@en-gb
Apolipoprotein A-V: a novel ap ...... ly phase of liver regeneration
@nl
P2093
P356
P1476
Apolipoprotein A-V: a novel ap ...... ly phase of liver regeneration
@en
P2093
A C Leegwater
H N van der Vliet
J H Levels
M G Sammels
P H Reitsma
R A Chamuleau
P304
P356
10.1074/JBC.M106888200
P407
P577
2001-11-30T00:00:00Z